|
|---|
|
13.00 - Get together and Introduction Session I (13:30 - 15:15) - Update on current ENS@T projects from the ACC and NAPACA Working group (chaired by B. Allolio) 13:30 - TIS11 family proteins and
the control of mRNA stability in the adrenal cortex 13:45 - BMP dependent effects on
adrenal tumorigenesis 14:00 - Potential role of type I
interferons in adrenocortical carcinoma growth 14:15 - Phenotypical characterization
of the NCI side population 14:30 - Uppsala experience of the
role of PET-scanning in management of ACC 14:45 - Prognostic markers of adrenal
cortical tumors: a molecular approach and The Carney complex
cohort: follow-up 15:00 Urinary steroid profiling via
GC/MS in ACC - first results of EURINE ACC Coffee break (15:15-15:30) Session II (15:30-17:15): Update on current ENS@T projects from the APA Working group (chaired by F. Mantero) 15:30 - Prospective comparison of
the captopril and the saline infusion test for excluding primary
aldosteronism due to aldosterone-producing adenoma: results
of the PAPY Study and proposal for collaborative studies 15:45 - Prediction of outcome in
168 patients with PA having undergone adrenalectomy 16:00 - Introduction of the German
Conn Registry 16:15 - Role of endothelial cells
in modulation of aldosterone release 16:30 - Quantitative expression of
urotensin-II and urotensin-II receptor in the normal human
adrenal gland, aldosterone-producing adenomas and pheochromocytoma.
16:40 - G-protein coupled receptor
expression in APA - microarray and RT-PCR results from Padua
and Paris 17:00 Aberrant receptor expression
in PA - clinical characterization Coffee break (17:15-17:30) 17:30 - Hereditary PGL in France:
the PGL.NET cohort 17:45 - Novel VHL mutations with
unusual clinical presentation 18:00 - Novel markers and targets
for the prognosis and treatment of malignant pheochromocytomas 18:15 - SDHB gene mutations predict
survival in patients with malignant PH and PGL 18:30 - Very low penetrance of SDHB
mutation in three Italian families with a large number of
carriers 18:45 - Detection of large rearrangements
in the PH/PGL genes using QMPSF 19:00 - A VHL intronic sequence variant
associated with pheochromocytoma Dinner (20:00 -23:00) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Saturday, November 04: Morning Session: Update on current "ENS@T projects" (09h00 - 12h00) Session IV (09:00-11:00): Proposal for future ENS@T projects (chaired by M. Reincke) 09:00 - Special topic: How to set
up a genetic screen for patients with sporadic PA 09:25 - Evaluation of adrenal masses:
the 18-FDG approach 09:40 - The metabolic syndrome in
patients with incidentally detected adrenal adenomas: evaluation
of the outcome of adrenalectomy compared to conservative management 09:55 - Quality control in laboratory
assessment of aldosterone and renin in biological fluids 10:10 - Genetic regulation of aldosterone:
interactions between CYP11B1 and CYP11B2 10:25 - Further implementation of
a European database of Pheo/PGL gene mutations and polymorphisms 10:40 - Multi-targeted tyrosin-kinase
inhibitor - new options for refractory ACC patients - discussion
of two potential phase II trials Coffee break (11:00) and End of Session ENS@T Steering committee meeting (11:00 - 14:00) 14:00 - End of Meeting * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * |